Inhibition of adaptive therapy tolerance in cancer: is triplet mitochondrial targeting the key?

Jukka Westermarck*

*Corresponding author for this work

Research output: Contribution to journalReview Article or Literature Reviewpeer-review

9 Citations (Scopus)
14 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Inhibition of adaptive therapy tolerance in cancer: is triplet mitochondrial targeting the key?'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science